Halofuginone Intermediate Synthesis via Mislow-Evans Rearrangement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic routes for the piperidine ring fragment of halofuginone suffer from low yields, high costs due to the use of expensive catalysts like Rh/Al2O3, hazardous lithium reagents, and complex workups, leading to unstable quality and high production costs.
Innovation Solution
A method involving Sulfinyl-Knoevenagel condensation and Mislow-Evans rearrangement using amino-substituted pentanal and thiazolyl sulfoxide compounds, followed by Lewis acid catalysis to produce trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, avoiding expensive catalysts and hazardous reagents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If Rh/Al2O3 catalyst is used for the synthesis of trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, then the reaction can proceed, but the production cost increases significantly
Solution Approach 1:
The patent replaces the expensive Rh/Al2O3 catalyst with a cheaper alternative catalyst system that can be used in conventional amounts without requiring expensive metal catalysts. This substitution directly addresses the technical contradiction by maintaining reaction feasibility while significantly reducing production costs.
Solution Approach 2:
The patent modifies the reaction parameters by changing the catalyst type, reaction conditions, and reagent system. These parameter changes enable the synthesis to proceed without expensive Rh/Al2O3 catalyst while achieving comparable or better yields, thus resolving the contradiction between reaction feasibility and production cost.
2Ease of manufacture
If lithium reagents are used as deprotonation reagents, then the reaction can proceed, but the labor protection intensity and safety risks increase
Solution Approach 1:
The patent replaces hazardous lithium reagents with safer alternative reagents that achieve the same deprotonation function without the associated safety risks and labor protection requirements. This substitution resolves the contradiction by maintaining reaction feasibility while eliminating harmful factors.
Solution Approach 2:
The patent transforms the harmful lithium reagent step into a beneficial process by using alternative reagents that are safer and easier to handle. The new reagent system maintains the necessary chemical reactivity while converting the harmful aspect into a safer operational procedure.
3Ease of manufacture
If existing synthetic routes are used for the piperidine ring fragment, then the intermediate can be produced, but the overall yield is low and quality is unstable
Solution Approach 1:
The patent systematically optimizes multiple reaction parameters including catalyst selection, reagent ratios, reaction temperature, and reaction time. These parameter changes collectively improve both the yield and quality stability of the intermediate product while maintaining ease of manufacture.
Solution Approach 2:
The patent implements process optimization based on reaction monitoring and quality control feedback. By adjusting reaction conditions based on observed outcomes, the method achieves consistent high yields and stable quality across multiple batches, resolving the contradiction between ease of manufacture and manufacturing precision.
4Manufacturing precision
If complex workup procedures are used, then the product purity can be improved, but the production time and operational complexity increase
Solution Approach 1:
The patent simplifies the workup procedure by extracting and removing impurities through optimized filtration and extraction steps, achieving high product purity without requiring complex multi-step purification procedures. This approach resolves the contradiction by maintaining product purity while reducing workup time and operational complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high yields and stable quality, providing a cost-effective and safer synthesis route for the critical intermediate of halofuginone, suitable for industrial application.
Implementation Method 1
A method involving Sulfinyl-Knoevenagel condensation and Mislow-Evans rearrangement using amino-substituted pentanal and thiazolyl sulfoxide compounds
Implementation Method 2
followed by Lewis acid catalysis to produce trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone
Data Source
AI summary
The present disclosure relates to the field of drug synthesis, and discloses a method for the preparation of trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as an intermediate of halofuginone. In the preparation method according to the present disclosure, for the first time, trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as shown in Formula I is obtained from amino-substituted pentanal and a thiazolyl sulfoxide compound as raw materials by Mislow-Evans rearrangement reaction and subsequent Lewis acid catalysis. The method for the preparation of trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as an intermediate of halofuginone according to the present disclosure has high yields and stable qualities, provides a new reference route for the synthesis of trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, avoids the reduction of pyridine, and overcomes the disadvantage of requiring the use of an expensive metal catalyst Rh/Al2O3.